SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,312,000 | +15.2% | 6,708 | +0.0% | 0.08% | +14.9% |
| Q2 2020 | $1,139,000 | +37.2% | 6,705 | -6.7% | 0.07% | +15.6% |
| Q1 2020 | $830,000 | -9.7% | 7,189 | -10.7% | 0.06% | +14.3% |
| Q4 2019 | $919,000 | +1020.7% | 8,047 | +734.8% | 0.06% | +1020.0% |
| Q3 2019 | $82,000 | +4000.0% | 964 | +3607.7% | 0.01% | – |
| Q2 2019 | $2,000 | -99.5% | 26 | -99.5% | 0.00% | -100.0% |
| Q1 2019 | $394,000 | -46.0% | 5,368 | +48700.0% | 0.03% | – |
| Q2 2018 | $730,000 | +6536.4% | 11 | -94.5% | 0.00% | -100.0% |
| Q3 2017 | $11,000 | -94.6% | 201 | -94.9% | 0.00% | -95.0% |
| Q2 2017 | $205,000 | +1266.7% | 3,950 | +1580.9% | 0.02% | +1900.0% |
| Q1 2017 | $15,000 | -94.4% | 235 | -95.4% | 0.00% | -96.2% |
| Q4 2016 | $268,000 | +605.3% | 5,078 | +493.2% | 0.03% | +766.7% |
| Q4 2015 | $38,000 | – | 856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |